4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046495
CEO and Chairman sold 41,035 shares at an average $37.42 ($1,535,408)
- CEO and Chairman sold 9,005 shares at $38.43 ($346,062)
- CEO and Chairman acquired 50,040 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-08-10 | Option exercise | +16,680 | $0.33 | $5,504 | 1,794,860 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-10 | Sale | −16,680 | $37.63 | $627,668 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-11 | Option exercise | +16,680 | $0.33 | $5,504 | 1,794,860 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-11 | Sale | −4,937 | $36.51 | $180,250 | 1,789,923 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-11 | Sale | −9,743 | $37.40 | $364,388 | 1,780,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-11 | Sale | −2,000 | $37.96 | $75,920 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-12 | Option exercise | +16,680 | $0.33 | $5,504 | 1,794,860 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-12 | Sale | −901 | $36.80 | $33,157 | 1,793,959 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-12 | Sale | −6,774 | $37.50 | $254,025 | 1,787,185 | D |
| ROBINS CHAD M CEO and Chairman | 2020-08-12 | Sale | +9,005 | $38.43 | $346,062 | 1,778,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-08-10 | Option exercise · Stock Option (Right to Buy) | −16,680 | 278,040 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-08-11 | Option exercise · Stock Option (Right to Buy) | −16,680 | 261,360 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-08-12 | Option exercise · Stock Option (Right to Buy) | −16,680 | 244,680 | D | ||
| Open-market sales · 50,040 sh · avg $37.60 · $1,881,470 | |||||||
Loading xslF345X03/doc4.xml…